STOCK TITAN

Verano Announces the Opening of MÜV Navarre, the Company’s 63rd Florida Location

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced the opening of MÜV Navarre, its 63rd Florida dispensary and 121st nationwide, on January 20, 2023. Located on Navarre Parkway, a key traffic area, this dispensary serves a community of nearly 40,000 residents. Florida's medical cannabis market is on a growth trajectory, with projected sales of $2.5 billion by 2026, supported by over 783,000 qualified medical cannabis patients. The dispensary will provide various services and products, including online consultations and a wide range of cannabis products. Verano operates in 13 states with over 1 million square feet of cultivation capacity.

Positive
  • Opening MÜV Navarre increases Verano's footprint in Florida with 121 dispensaries nationwide.
  • MÜV Navarre provides access to a rapidly growing market, projected to reach $2.5 billion by 2026.
Negative
  • None.
  • MÜV is the first medical cannabis dispensary in Navarre, a town with a population of nearly 40,0001
  • MÜV Navarre is located at 6863 Navarre Parkway, a busy thoroughfare with an average daily traffic count of 37,500 vehicles2
  • Verano’s active operations span 13 states, comprised of 121 dispensaries and 14 cultivation and processing facilities with more than 1 million square feet of cultivation capacity

CHICAGO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of MÜV Navarre on Friday, January 20, the Company’s 63rd Florida dispensary and 121st nationwide. MÜV Navarre, located at 6863 Navarre Parkway, is open Monday through Saturday from 9 a.m. to 5 p.m. and Sunday from 11 a.m. to 5 p.m., local time.

According to Florida’s Office of Medical Marijuana Use, there are currently over 783,000 qualified medical cannabis patients in the state. Florida medical cannabis sales are projected to potentially reach $2.5 billion by 2026, as reported by MJBiz Factbook 2022.

“We’re excited to welcome patients at MÜV Navarre, the city’s first medical cannabis dispensary, where our dedicated team of cannabis advisors will provide guidance and care to patients throughout the Panhandle,” said John Tipton, President of Verano. “Opening MÜV Navarre compliments our existing dispensaries in Pensacola and Shalimar, and we’re thrilled to add another convenient location for Florida’s medical cannabis patients and increase their access to medicine.”

As a demonstration of Verano’s commitment to provide a convenient and reliable experience for Florida patients, MÜV dispensaries feature online menus for effortless browsing of their extensive, award-winning product selection, including the Company’s signature Verano Reserve and Sweet Supply flower, Encore edibles, and Savvy flower and extracts. The Company also offers one-on-one virtual and in-store consultations at no cost to the patient and provides patient-centric concierge services via phone, email, web chat and text to address patient questions and inquiries. For additional convenience and accessibility, patients can choose to order ahead at muvfl.com or through the MÜV mobile application available in the Google Play and Apple App stores for express in-store pickup.

MÜV’s comprehensive product selection includes edibles, chocolates and lozenges, flower, pre-rolls, an array of vaporizer pens, concentrates, metered-dose inhalers, topicals and oral sprays; along with patented encapsulation formulations in its EnCaps capsules, tinctures, 72-hour transdermal patches and transdermal gels.

For more information about MÜV Navarre medical cannabis dispensary, visit muvfl.com.

About Verano

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano, Avexia, Encore, and MÜV. Verano’s portfolio encompasses 14 U.S. states, with active operations in 13, including 13 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf and MÜV, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.

Contacts:

Media
Verano
Grace Bondy
Manager, Communications
Grace.Bondy@verano.com

Investors
Verano
Julianna Paterra, CFA
Director, Investor Relations
Julianna.Paterra@verano.com

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s registration statement on Form 10, as amended, and quarterly reports on Form 10-Q filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###


1 United States Census Bureau
2 Florida Department of Transportation


FAQ

When did Verano open MÜV Navarre?

Verano opened MÜV Navarre on January 20, 2023.

What is the significance of MÜV Navarre for Verano?

MÜV Navarre is Verano's 63rd Florida dispensary and 121st nationwide, enhancing access to medical cannabis for patients.

What are the projected medical cannabis sales in Florida?

Florida's medical cannabis sales are projected to reach $2.5 billion by 2026.

How many dispensaries does Verano operate?

Verano operates 121 dispensaries across 13 states.

What services are offered at MÜV Navarre?

MÜV Navarre offers online consultations, a range of cannabis products, and patient-centric concierge services.

VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

610.70M
302.30M
15.59%
10.6%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago